CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biopharmaceutical company focused on developing therapeutics targeting Toll-Like Receptors (TLR), today announced that it will present at the Wachovia 2008 Healthcare Conference. The Company will discuss its TLR-targeted drug discovery and development programs and provide a general corporate update. The presentation will be delivered on Wednesday, January 30, 2008 at 1:30 p.m. (EST) at the Langham Hotel in Boston, MA.
